Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Cantor Fitzgerald
QuintilesIMS
Argus Health
Daiichi Sankyo
Federal Trade Commission

Generated: July 23, 2019

DrugPatentWatch Database Preview

Patent: 7,196,244

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,196,244
Title:Method of transposon-mediated mutagenesis in the nematode caenorhabditis elegans
Abstract: The present invention provides methods for generating and identifying mutations in Caenorhabditis elegans. Disclosed herein are methods for introducing DNA into the C. elegans germline, methods for expressing DNA in the C. elegans germline, and methods for generating C. elegans mutants by using controlled mobilization of endogenous and heterologous transposons. Also disclosed are a transgene construct for expression in C. elegans and methods for inserting single copy DNA sequences into the C. elegans germline, and engineering mutations into the C. elegans genome.
Inventor(s): Bessereau; Jean-Louis (Paris, FR), Jorgensen; Erik M. (Salt Lake City, UT)
Assignee: University of Utah (Salt Lake City, UT)
Application Number:09/980,644
Patent Claims:see list of patent claims

Details for Patent 7,196,244

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up University of Utah (Salt Lake City, UT) ➤ Sign Up RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up University of Utah (Salt Lake City, UT) ➤ Sign Up RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up University of Utah (Salt Lake City, UT) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 7,196,244

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 0073510 Aug 08, 2002
World Intellectual Property Organization (WIPO) 0073510 Dec 07, 2000
European Patent Office 1187938 Jul 05, 2006
European Patent Office 1187938 Mar 20, 2002
European Patent Office 1187938 Nov 09, 2011
European Patent Office 2395094 Apr 18, 2012
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Merck
Fuji
Baxter
UBS
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.